Sean Bohen - 07 Sep 2021 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role: PRESIDENT AND CEO, Director
Signature: /s/ John B. Moriarty, Jr., Attorney-in-Fact
Issuer symbol: OLMA
Transactions as of: 07 Sep 2021
Net transactions value: -$76,669
Form type: 4
Filing time: 09 Sep 2021, 16:25:20 UTC
Previous filing: 03 Sep 2021
Next filing: 29 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OLMA	Common Stock	Options Exercise	$1,992	+413	+0.76%	$4.82	54,687	07 Sep 2021	Direct
transaction	OLMA	Common Stock	Sale	$12,423	-413	-0.76%	$30.08	54,274	07 Sep 2021	Direct	F1, F2
transaction	OLMA	Common Stock	Options Exercise	$12,692	+2,631	+4.8%	$4.82	56,905	08 Sep 2021	Direct
transaction	OLMA	Common Stock	Sale	$78,930	-2,631	-4.8%	$30.00	52,514	08 Sep 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OLMA	Stock Option (Right to Buy)	Options Exercise	$0	-413	-0.04%	$0.000000	975,032	07 Sep 2021	Common Stock	413	$4.82	Direct	F3
transaction	OLMA	Stock Option (Right to Buy)	Options Exercise	$0	-2,631	-0.27%	$0.000000	972,401	08 Sep 2021	Common Stock	2,631	$4.82	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
F2	The weighted average sale price for the transaction reported was $30.08, and the range of prices were between $30.00 and $30.12. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F3	(A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable.